| EZH2 Inhibitor Zeprumetostat in Combination Therapy for Patients With Relapsed or Refractory Mature T-cell and NK-cell Lymphomas (NCT07339527) | Sun Yat-sen University | 2026-01-01 |
| A Single-Arm Phase II Clinical Study of Docetaxel Combined With Nimotuzumab and Pucotenlimab as Second-Line and Beyond Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (NCT07354984) | Sun Yat-sen University | 2026-01-01 |
| Effect of Intrathecal Morphine on Quality of Recovery After Laparoscopic Gynecological Surgery (NCT07322029) | Sun Yat-sen University | 2026-01-01 |
| A Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade in Patients With Locally Advanced Non-Small Cell Lung Cancer (NCT07103395) | Sun Yat-sen University | 2026-01-01 |
| Magnetic Tracking and ECG-Guided Tip Confirmation System for PICCs (NCT07369427) | Sun Yat-sen University | 2026-01-01 |
| PD-1 + FOLFOXIRI vs CAPOX as Total Neoadjuvant Therapy for pMMR Low Rectal Cancer (NCT07277842) | Sun Yat-sen University | 2025-12-29 |
| A Virtual Peer Agent for Counseling Adolescents With Stressful Life Events (NCT07305064) | Sun Yat-sen University | 2025-12-26 |
| Garsorasib In KRAS G12C Mutant Locally Advanced and Metastatic NSCLC (NCT07294261) | Sun Yat-sen University | 2025-12-23 |
| A Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan in Second-Line and Subsequent Treatments for Advanced Thymic Epithelial Tumors (NCT07343453) | Sun Yat-sen University | 2025-12-22 |
| SIB-RT Combined With CAPOX and PD-1 for High-Risk Rectal Cancer (NCT07297030) | Sun Yat-sen University | 2025-12-20 |
| Prospective Geometric Analysis of Ultra-Widefield OCTA Characteristics in Central Serous Chorioretinopathy Patients (NCT07347119) | Sun Yat-sen University | 2025-12-18 |
| Ipromlimab and Tuvonralimab Combined With Albumin-Bound Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma (NCT07374003) | Sun Yat-sen University | 2025-12-17 |
| Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral Liquid (NCT07311772) | Sun Yat-sen University | 2025-12-16 |
| Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma (NCT07238569) | Sun Yat-sen University | 2025-12-01 |
| Trifluridine/Tipiracil Plus Fruquintinib vs. Trifluridine/Tipiracil Plus Bevacizumab in Refractory Metastatic Colorectal Cancer: A Randomized, Controlled, Open-Label, Non-Inferiority Trial (NCT07261709) | Sun Yat-sen University | 2025-12-01 |
| TAF Monotherapy Versus ETV Combined With TAF on the Efficacy and Prognosis of Immunotherapy for Hepatitis B-Related Hepatocellular Carcinoma (NCT07253220) | Sun Yat-sen University | 2025-12-01 |
| A Phase I Study of WTX212A Monotherapy or in Combination With Radiotherapy in Patients With Advanced Solid Tumors (NCT07269899) | Sun Yat-sen University | 2025-11-25 |
| A Study of Tumor-Agnostic MRD Detection in Stage III Colorectal Cancer (NCT07254156) | Sun Yat-sen University | 2025-11-24 |
| Iparomlimab and Tuvonralimab (QL1706) Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC (NCT07389629) | Sun Yat-sen University | 2025-11-21 |
| PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Salvage Locoregional Radiotherapy in De Novo Metastatic NPC (NCT07235319) | Sun Yat-sen University | 2025-11-20 |
| Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC) (NCT07241793) | Sun Yat-sen University | 2025-11-20 |
| Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma. (NCT07201337) | Sun Yat-sen University | 2025-11-17 |
| Adaptive Immunotherapy for Nasopharyngeal Carcinoma (NCT07154069) | Sun Yat-sen University | 2025-11-13 |
| Neoadjuvant SBRT and Tislelizumab (Immunotherapy) Plus Anlotinib for Resectable EGFR Wild-type NSCLC (NCT07231575) | Sun Yat-sen University | 2025-11-10 |
| Dalpiciclib Plus Camrelizumab for HCC Patients Who Have Previously Received ICI Treatment (NCT07238881) | Sun Yat-sen University | 2025-11-05 |
| Serplulimab, Chidamide, and Rituximab Followed by Sequential R-CHOP for Newly Diagnosed Elderly MYC/BCL2 Double-Expressor DLBCL (NCT07538180) | Sun Yat-sen University | 2025-10-30 |
| Risk Factors Affecting MSC Efficacy in ACLF Patients (NCT07198854) | Sun Yat-sen University | 2025-10-20 |
| Iparomlimab and Tuvonralimab Combined With Nimotuzumab in Recurrent or Metastatic NPC After First-line Treatment Failure: A Single-arm Phase IIa Clinical Trial (NCT07101744) | Sun Yat-sen University | 2025-10-17 |
| Fruquintinib Combined With Standard Chemotherapy Versus Standard Chemotherapy as First-line Treatment for Advanced pMMR Endometrial Cancer (NCT07170982) | Sun Yat-sen University | 2025-10-15 |
| Anlotinib Hydrochloride Capsules in Maintenance Treatment for Intermediate-High Risk Rhabdomyosarcoma in Children (NCT07137884) | Sun Yat-sen University | 2025-10-01 |
| The IVO-LUNG Study (NCT07204548) | Sun Yat-sen University | 2025-10-01 |
| A Study Evaluating Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade for Limited-stage Small Cell Lung Cancer (NCT07103408) | Sun Yat-sen University | 2025-10-01 |
| Transcatheter Edge-to-Edge Repair In Moderate and Exertional-Induced Severe MR (TIMER) (NCT07197021) | Sun Yat-sen University | 2025-10-01 |
| QL1706 in the Treatment of Advanced Bone and Soft Tissue Sarcoma (NCT06939855) | Sun Yat-sen University | 2025-09-28 |
| QL1706 With Short-Course Radiotherapy and Chemotherapy for MSS Rectal Cancer (NCT07175636) | Sun Yat-sen University | 2025-09-20 |
| Neoadjuvant Immunochemotherapy and Postoperative Adjuvant Immunotherapy for Head and Neck Squamous Cell Carcinoma Invading the Skull Base (NCT07145931) | Sun Yat-sen University | 2025-09-20 |
| Systemic Chemotherapy With FOLFOX Plus Atezolizumab & Bevacizumab for Patients With Advanced HCC Who Previously Received Atezolizumab & Bevacizumab (NCT07192185) | Sun Yat-sen University | 2025-09-17 |
| Relmacabtagene Autoleucel Combined With Sintilimab for Relapsed/Refractory B-cell Lymphoma (NCT07077512) | Sun Yat-sen University | 2025-09-15 |
| A Prospective, Randomized, Multicenter Clinical Study Comparing Adjuvant Radiotherapy Versus Observation in High-risk Localized Adrenocortical Carcinoma After Surgery. (NCT07141147) | Sun Yat-sen University | 2025-09-15 |
| Linperlisib Combined With Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma (NCT07139353) | Sun Yat-sen University | 2025-09-15 |
| Adaptive Chemotherapy for the Treatment of Advanced Breast Cancer (NCT07088263) | Sun Yat-sen University | 2025-09-15 |
| Xinlikang Capsule for Chemotherapy-induced Fatigue and Immune Disorders in Diffuse Large B Lymphoma (NCT07084662) | Sun Yat-sen University | 2025-09-11 |
| MAIC of Fruquintinib Plus Paclitaxel Versus Ramucirumab Plus Paclitaxel in Advanced G/GEJ Adenocarcinoma (NCT07144995) | Sun Yat-sen University | 2025-09-05 |
| Nintedanib for Improving Reproductive Outcomes in Adenomyosis (NCT07162961) | Sun Yat-sen University | 2025-09-01 |
| EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal Carcinoma (NCT07138989) | Sun Yat-sen University | 2025-08-19 |
| Comparing Postoperative Adjuvant Cisplatin Concurrent Chemoradiotherapy With Adjuvant Radiotherapy Alone for Intermediate-risk Head and Neck Squamous Cell Carcinoma (NCT07125755) | Sun Yat-sen University | 2025-08-15 |
| Ivonescimab (AK112) Plus Paclitaxel as Second-line Therapy in Patients With Advanced G/GEJ Cancer (NCT06904300) | Sun Yat-sen University | 2025-08-15 |
| Radiotherapy Omitting Prophylactic Neck Irradiation With Neoadjuvant and Adjuvant Toripalimab in Nasopharyngeal Carcinoma (NCT07110558) | Sun Yat-sen University | 2025-08-15 |
| AK112 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI as Second-line Treatment of MSS/pMMR Metastatic Colorectal Cancer (NCT07021950) | Sun Yat-sen University | 2025-08-10 |
| A Phase II, Single-Arm, Prospective Trial on the Efficacy and Safety of QL1706 Combination Regimen as Second-Line Therapy for Targeted-Immunotherapy-Resistant Hepatocellular Carcinoma (NCT07138885) | Sun Yat-sen University | 2025-08-01 |
| Feasibility Study of Home Cardiac Rehabilitation Program for Postoperative Children With Congenital Heart Disease (NCT07055347) | Sun Yat-sen University | 2025-08-01 |
| Selective Total Mesorectal Excision Based on Intra-Operative Frozen Section From Local Excision in Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy (NCT07337811) | Sun Yat-sen University | 2025-08-01 |
| Mechanism and Effect of Novel Metabolites on Valvular Heart Disease (NCT07065500) | Sun Yat-sen University | 2025-08-01 |
| Combination of Concurrent Chemoradiotherapy With Surufatinib and Tislelizumab in Patients With Locally Advanced Non-Small Cell Lung Cancer (NCT07086456) | Sun Yat-sen University | 2025-07-20 |
| Surufatinib in Combination With Neoadjuvant Chemo-immunotherapy and Concurrent Chemoradiotherapy for Patients With Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma (NCT07086469) | Sun Yat-sen University | 2025-07-20 |
| Validation of Insulin Dose Prediction Model Based on Artificial Intelligence Algorithm (NCT07066891) | Sun Yat-sen University | 2025-07-15 |
| Dual EGFR/HER2 Blockade Combined With Irinotecan for the Treatment of HER2-Positive Metastatic Colorectal Cancer (NCT07059338) | Sun Yat-sen University | 2025-07-11 |
| Pucotenlimab Combination With Vorolanib as Neoadjuvant Therapy for ccRCC (NCT07386158) | Sun Yat-sen University | 2025-07-10 |
| A Trial of Recaticimab and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable BTC (NCT07062328) | Sun Yat-sen University | 2025-07-10 |
| Artificial Intelligence Diagnosis of Different Histopathological Growth Patterns of Colorectal Cancer Liver Metastasis (NCT07088393) | Sun Yat-sen University | 2025-07-09 |
| EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma (NCT06802835) | Sun Yat-sen University | 2025-07-09 |
| Assessing An Oral JAK1 Inhibitor, Golidocitinib, in Patients Who Have Newly Diagnosed Peripheral T-Cell Lymphoma (JACKPOT23) (NCT07032532) | Sun Yat-sen University | 2025-07-01 |
| Tislelizumab Combined With Fruquintinib for Metastatic pMMR/MSS Colorectal Cancer (NCT05690035) | Sun Yat-sen University | 2025-07-01 |
| ScreenTalk to Improve Colorectal Cancer Screening Uptake Among First-degree Relatives of Patients: a Study Protocol (NCT06710860) | Sun Yat-sen University | 2025-07-01 |
| A Multi-omics Study of BRAF V600E Mutant Colorectal Cancer (NCT07007689) | Sun Yat-sen University | 2025-07-01 |
| Hypofractionated Versus Conventional Chemoradiotherapy Followed by Consolidative Immunotherapy in Locally Advanced NSCLC (NCT07052669) | Sun Yat-sen University | 2025-07-01 |
| Transanal Total Mesorectal Excision vs Robotic Total Mesorectal Excision (NCT07651553) | Sun Yat-sen University | 2025-06-30 |
| Tislelizumab Combined With SBRT for the Treatment of Head and Neck Squamous Cell Carcinoma (NCT06673693) | Sun Yat-sen University | 2025-06-25 |
| Evaluation of WGc-043 Injection in Advanced Solid Tumors: Phase I Study (NCT07028047) | Sun Yat-sen University | 2025-06-23 |
| Neoadjuvant Chemoradiotherapy Plus Sintilimab for MSS, Locally Advanced Rectal Cancer- (NCT06895577) | Sun Yat-sen University | 2025-06-20 |
| Effectiveness Evaluation of the "Mosquito-Free Campus" Initiative on Dengue Fever Prevention and Control: A Cluster Randomized Controlled Trial (NCT07002021) | Sun Yat-sen University | 2025-06-15 |
| A Study of Almonertinib Combined With Palbociclib in Patients With Advanced Solid Tumors Harboring KRAS Mutations (NCT06947811) | Sun Yat-sen University | 2025-06-09 |
| Omitting CTV for Primary Tumor in LS-SCLC (NCT07008716) | Sun Yat-sen University | 2025-06-03 |
| Toripalimab Plus Celecoxib for dMMR/MSI-H Locally Advanced Colorectal Cancer (NCT06903858) | Sun Yat-sen University | 2025-06-01 |
| ctDNA-Guided Cetuximab or Bevacizumab Plus Trifluridine/Tipiracil in RAS/BRAF Wild-Type mCRC (NCT07012954) | Sun Yat-sen University | 2025-06-01 |
| A Clinical Study to Evaluate the Efficacy and Safety of Envafolimab Combined With Cetuxima-βand mFOLFOX6 in Patients With MSS, RAS/BRAF Wild-Type Metastatic Colorectal Cancer (mCRC) (NCT06959693) | Sun Yat-sen University | 2025-06-01 |
| Pelvic Floor Peritoneal Closure to Prevent Postoperative Ileus in Mid-Low Rectal Cancer Surgery (NCT07432542) | Sun Yat-sen University | 2025-06-01 |
| Safety and Efficacy of IB-FOLFIRI in BRAF V600E-Mutant Metastatic Colorectal Cancer (NCT07150247) | Sun Yat-sen University | 2025-06-01 |
| New Triple Therapy in Newly Diagnosed Type 2 Diabetes (NCT06946628) | Sun Yat-sen University | 2025-06-01 |
| Intraoperative Rectal Lavage to Prevent Local Recurrence After Laparoscopic Mid-to-Low Rectal Cancer Resection: A Multicenter Randomized Trial (NCT07512232) | Sun Yat-sen University | 2025-06-01 |
| TC as Adjuvant Therapy After Surgery for Locally Recurrent Resectable Nasopharyngeal Carcinoma: a Single-arm Clinical Trial (NCT06987123) | Sun Yat-sen University | 2025-05-18 |
| TN Induction and Adjuvant Therapy for Resectable Local Recurrent Nasopharyngeal Carcinoma (NCT06912711) | Sun Yat-sen University | 2025-05-16 |
| Prophylactic or Preemptive Entecavir in Patients With Gastrointestinal Cancer Who Are Inactive Hepatitis B Carriers (NCT06966232) | Sun Yat-sen University | 2025-05-15 |
| Safety and Efficacy of Pucotenlimab in pLECC (NCT06969534) | Sun Yat-sen University | 2025-05-15 |
| The Application of Lidocaine Cream on Oral Secretions of LMA Removal During the Recovery Period in Ophthalmic Surgical Patients Under General Anesthesia (NCT06967064) | Sun Yat-sen University | 2025-05-15 |
| PROPHET Study: ctDNA-Guided Personalized Induction Immunochemotherapy for NSCLC (NCT06977074) | Sun Yat-sen University | 2025-05-10 |
| Risk Assessment for HBV-Related Liver Cancer (NCT07160946) | Sun Yat-sen University | 2025-05-10 |
| Chemoimmunotherapy With or Without SBRT Before Surgery for Locally Advanced Oral and Oropharyngeal Cancer (NCT06861712) | Sun Yat-sen University | 2025-05-06 |
| An AI Educational Agent for Medical Machine Learning Courses (NCT07449182) | Sun Yat-sen University | 2025-05-01 |
| Obinutuzumab With CHOP Versus Obinutuzumab With Bendamustine in the Treatment of Newly Diagnosed Follicular Lymphoma Grade 3A (NCT06961500) | Sun Yat-sen University | 2025-05-01 |
| PD-1 Antibody Sintilimab Combined With Capecitabine as Adjuvant Therapy for High-Risk Nasopharyngeal Carcinoma (NCT06900218) | Sun Yat-sen University | 2025-05-01 |
| Anlotinib Combined With Benmelstobart for Advanced Pheochromocytoma (NCT06429397) | Sun Yat-sen University | 2025-05-01 |
| Disitamab Vedotin Combined With Ivonescimab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer (NCT06957561) | Sun Yat-sen University | 2025-04-30 |
| Radiotherapy Plus Iparomlimab and Tuvonralimab (QL1706), Regorafenib, and CAPOX as Neoadjuvant Therapy for pMMR/MSS LARC. (NCT06911684) | Sun Yat-sen University | 2025-04-30 |
| Neoadjuvant CAPOX Plus Ivonescimab Versus CAPOX for Locally Advanced Colon Cancer (NCT06790212) | Sun Yat-sen University | 2025-04-28 |
| Postoperative EGFR-TKI Therapy forContralateral Pulmonary Nodules in Patients With EGFR-Mutant NSCLC（ARMOR2501） (NCT06924398) | Sun Yat-sen University | 2025-04-20 |
| GP Combined with Toripalimab Versus GP Induction Chemotherapy for Advanced Childhood Nasopharyngeal Carcinoma (NCT06605131) | Sun Yat-sen University | 2025-04-17 |
| Phase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing Sarcoma (NCT06827717) | Sun Yat-sen University | 2025-04-15 |
| Acalabrutinib Plus Rituximab for the Treatment of Elderly or Low- to Intermediate-Risk Younger Untreated Mantle Cell Lymphoma (NCT06846489) | Sun Yat-sen University | 2025-04-14 |
| Pucotenlimab Combined With Lenvatinib and Chemotherapy in the Treatment of Advanced, Relapsed/Refractory Hepatoblastoma in Children (NCT07188311) | Sun Yat-sen University | 2025-04-10 |